Skip to main content
. 2023 Mar 9;24(6):5270. doi: 10.3390/ijms24065270
ADHD attention deficit hyperactivity disorder
AMP amphetamine
ASC amphetamine salt combination
ASMs antiseizure medications
BECTS benign epilepsy with centrotemporal spikes
BRE benign rolandic epilepsy
CAE childhood absence epilepsy
CWE children with epilepsy
DAS dextroamphetamine sulfate
DAT dopamine transporters
D-MPH dexmethylphenidate hydrochloride
DNRI dopamine and norepinephrine reuptake inhibitor
DSM Diagnostic and Statistical Manual of Mental Disorders
EEG electroencephalogram
FDA Food and Drug Administration
FLE frontal lobe epilepsy
GABA γ-aminobutyric acid
GWAS genome-wide association studies
ILAE International League Against Epilepsy
IQ intelligence quotient
LDX lisdexamfetamine dimesylate
MAH methamphetamine hydrochloride
MECP2 methyl-CpG binding protein 2
MEF2C myocyte enhancer factor 2
MPH methylphenidate
MPHH methylphenidate hydrochloride
NET norepineph- rine transporter
SBG Scutellaria baicalensis Georgi
SDX Serdexmethylphenidate
SEEG stereo electroencephalogram
SERT serotonin transporter
SNP single nucleotide polymorphism
VMAT2 vesicular monoamine transporter 2
VTX Vortioxetine